Episode 239: The STAMPEDE trial

Nick James, MBBS, PhD, joins us to discuss the success of the STAMPEDE trial, a multi-arm study on the use of abiraterone in patients with prostate cancer who are initiating long-term ADT.
Dr. James is a urologist and Professor of Prostate and Bladder Cancer Research at the Institute of Cancer Research in London, with a focus on bladder and prostate cancer as well as novel trial design.